Skip to main content
. 2017 Jul 29;2(6):1208–1218. doi: 10.1016/j.ekir.2017.07.007

Figure 5.

Figure 5

Comparison of (a) vimentin_1 and (b) α-1-microglobulin/bikunin precursor (AMBP) spot volumes between controls (n = 7, gray fill), lean chronic kidney disease (CKD) patients (n = 13, light blue fill), and obese CKD patients (n = 9, dark blue fill). *P ≤ 0.05, **P ≤ 0.01 for differences between the groups (analysis of variance followed by Fisher least significant difference post hoc tests). Box plots represent median (within-box line), minimum, and maximum values (whiskers).